Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Teodora-Ecaterina M Manuc, Mircea M Manuc & Mircea M Diculescu. (2016) Recent insights into the molecular pathogenesis of Crohn’s disease: a review of emerging therapeutic targets. Clinical and Experimental Gastroenterology 9, pages 59-70.
Read now
Read now
Dino Tarabar, Ayal Hirsch & David T. Rubin. (2016) Vedolizumab in the treatment of Crohn’s disease. Expert Review of Gastroenterology & Hepatology 10:3, pages 283-290.
Read now
Read now
Leah Gilroy & Patrick B Allen. (2014) Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn’s disease?. Clinical and Experimental Gastroenterology 7, pages 163-172.
Read now
Read now
Articles from other publishers (6)
Arlene Bravo & Arthur Kavanaugh. (2019) Bedside to bench: defining the immunopathogenesis of psoriatic arthritis. Nature Reviews Rheumatology 15:11, pages 645-656.
Crossref
Crossref
Alessandro Armuzzi, Paolo Gionchetti, Marco Daperno, Silvio Danese, Ambrogio Orlando, Maria Lia Scribano, Maurizio Vecchi, Fernando Rizzello, Sandro Ardizzone, Alessandro Armuzzi, Fabiana Castiglione, Silvio Danese, Marco Daperno, Massimo Fantini, Gionata Fiorino, Giuseppe Frieri, Paolo Gionchetti, Luca Neri, Ambrogio Orlando, Fernando Rizzello, Maria Lia Scribano, Giacomo Carlo Sturniolo & Maurizio Vecchi. (2016) Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease. Digestive and Liver Disease 48:4, pages 360-370.
Crossref
Crossref
P. K. Shukla, Pratiksha Singh, Ravindra Kumar Yadav, Smriti Pandey & Shome S. Bhunia. 2018. Communicable Diseases of the Developing World. Communicable Diseases of the Developing World
125
167
.
RV Bryant, WJ Sandborn & SPL Travis. (2015) Introducing Vedolizumab to Clinical Practice: Who, When, and How?. Journal of Crohn's and Colitis 9:4, pages 356-366.
Crossref
Crossref
Lianjie Lin, Xiang Liu, Dongxu Wang & Changqing Zheng. (2015) Efficacy and Safety of Antiintegrin Antibody for Inflammatory Bowel Disease. Medicine 94:10, pages e556.
Crossref
Crossref
Man Cai Wang, Ling Yi Zhang, Wei Han, Yuan Shao, Mo Chen, Rui Ni, Gen Nian Wang, Feng Xian Wei, Ya Wu Zhang, Xiao Dong Xu & You Cheng Zhang. (2014) PRISMA—Efficacy and Safety of Vedolizumab for Inflammatory Bowel Diseases. Medicine 93:28, pages e326.
Crossref
Crossref